Dusan Stefoski to Odds Ratio
This is a "connection" page, showing publications Dusan Stefoski has written about Odds Ratio.
Connection Strength
0.019
-
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol. 2009 Mar; 8(3):254-60.
Score: 0.019